Knockdown of JARID2 has been reported to impair the invasive and tumorigenic abilities of bladder cancer cells, reducing the number of tumor-initiating cells, suggesting an important role of JARID2 in the progression of OSCC [18]. Here, JARID2 is linked to urinary bladder cancer.